loading
전일 마감가:
$1.865
열려 있는:
$1.83
하루 거래량:
266.99K
Relative Volume:
0.20
시가총액:
$205.83M
수익:
$42.51M
순이익/손실:
$-116.49M
주가수익비율:
-1.6786
EPS:
-1.12
순현금흐름:
$-120.82M
1주 성능:
+25.67%
1개월 성능:
+28.23%
6개월 성능:
-51.91%
1년 성능:
-73.41%
1일 변동 폭
Value
$1.79
$1.91
1주일 범위
Value
$1.47
$3.00
52주 변동 폭
Value
$1.03
$12.02

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
명칭
Tango Therapeutics Inc
Name
전화
(857) 320-4900
Name
주소
201 BROOKLINE AVENUE, BOSTON
Name
직원
155
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
TNGX's Discussions on Twitter

TNGX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TNGX
Tango Therapeutics Inc
1.899 164.76M 42.51M -116.49M -120.82M -1.12
Biotechnology icon
ONC
Beigene Ltd Adr
241.16 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
431.36 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.33 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.22 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.15 5.92B 0 -153.72M -103.81M -2.00

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-07-17 개시 Jefferies Buy
2024-04-04 개시 Cantor Fitzgerald Overweight
2024-02-12 개시 Piper Sandler Overweight
2023-12-08 개시 B. Riley Securities Buy
2022-10-20 업그레이드 H.C. Wainwright Neutral → Buy
2021-09-20 개시 SVB Leerink Outperform
모두보기

Tango Therapeutics Inc 주식(TNGX)의 최신 뉴스

pulisher
May 22, 2025

Tango Therapeutics doses first subject in trial for MTAP-deleted tumours - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Tango Therapeutics starts trial for brain cancer drug By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

TNGX Initiates Phase 1/2 Trial for MTAP-Deleted Tumors | TNGX Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Tango Therapeutics Announces First Patient Dosed in TNG456 - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Tango Launches Phase 1/2 Trial for Brain Cancer Drug: New Hope for Deadly Glioblastoma Treatment - Stock Titan

May 21, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Issues Positive Estimate for TNGX Earnings - Defense World

May 18, 2025
pulisher
May 16, 2025

Leerink Partnrs Analysts Boost Earnings Estimates for TNGX - Defense World

May 16, 2025
pulisher
May 15, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Purchases 302,087 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

May 15, 2025
pulisher
May 15, 2025

Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 15, 2025
pulisher
May 14, 2025

Tango Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Holdings Boosted by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 13, 2025

Tango Therapeutics Extends Cash Runway Amid Clinical Progress - TipRanks

May 13, 2025
pulisher
May 12, 2025

Tango Therapeutics (TNGX) Plans $400 Million Mixed Securities Sh - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Files For Mixed Shelf Of Up To $400 Million - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Inc (TNGX) Q1 2025 Earnings: EPS of -$0.36 Mi - GuruFocus

May 12, 2025
pulisher
May 12, 2025

TNGX Reports Q1 Revenue Miss, Advances Cancer Treatments | TNGX Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Has $307,000 Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

May 12, 2025
pulisher
May 10, 2025

Tango Therapeutics (TNGX) to Release Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Insights into Tango Therapeutics's Upcoming Earnings - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of “Buy” by Analysts - Defense World

May 09, 2025
pulisher
May 08, 2025

21,500 Shares in Tango Therapeutics, Inc. (NASDAQ:TNGX) Acquired by Renaissance Technologies LLC - Defense World

May 08, 2025
pulisher
May 06, 2025

JPMorgan Chase & Co. Has $97,000 Stock Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

May 06, 2025
pulisher
May 05, 2025

Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

Medivir's Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study - Barchart.com

May 05, 2025
pulisher
May 01, 2025

There is no way Tango Therapeutics Inc (TNGX) can keep these numbers up - Sete News

May 01, 2025
pulisher
May 01, 2025

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 - GlobeNewswire

May 01, 2025
pulisher
Apr 30, 2025

Is Tango Therapeutics Inc (TNGX) worth investing in despite its undervalued state? - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Tango Therapeutics Inc (TNGX) Stock: A Year of Highs and Lows - investchronicle.com

Apr 30, 2025
pulisher
Apr 29, 2025

Insider’s View: Deciphering Tango Therapeutics Inc (TNGX)’s Financial Health Through Ratios - DWinneX

Apr 29, 2025
pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 27, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Now Is The Time To Build A Position In Tango Therapeutics Inc (NASDAQ:TNGX) - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Gaining Ground: Tango Therapeutics Inc (TNGX) Closes Lower at 2.35, Down -0.42 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

What is the investor’s view on Tango Therapeutics Inc (TNGX)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 18, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by Franklin Resources Inc. - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives $12.33 Average PT from Analysts - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Equities Analysts Offer Predictions for TNGX Q1 Earnings - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Tango Bypasses IPO Route With SPAC Merger - insights.citeline.com

Apr 16, 2025
pulisher
Apr 16, 2025

What is HC Wainwright’s Estimate for TNGX Q1 Earnings? - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Tango Therapeutics’ (TNGX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Tango Therapeutics stock holds Buy rating, $13 target from H.C. Wainwright - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Tango Therapeutics stock holds Buy rating, $13 target from H.C. Wainwright By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Little Excitement Around Tango Therapeutics, Inc.'s (NASDAQ:TNGX) Revenues As Shares Take 28% Pounding - simplywall.st

Apr 14, 2025

Tango Therapeutics Inc (TNGX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.19
price down icon 13.67%
$31.50
price down icon 3.35%
$578.71
price down icon 0.54%
$285.49
price down icon 1.39%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
자본화:     |  볼륨(24시간):